Abstract
- Differentiated thyroid carcinoma is a rare disease. Appropriate diagnosis, treatment and follow-up are complex but greatly influence treatment outcomes and patient quality of life. - Patients with differentiated thyroid carcinoma present in many hospitals throughout the Netherlands, underscoring the need for uniformity in diagnosis and treatment. - This prompted the Dutch Society of Nuclear Medicine and the Dutch Endocrine Society to develop an evidence-based guideline that emphasises not only new scientific developments but also the organisation of care. - Thyroid-stimulating hormone (TSH) assessment and fine needle aspiration cytology play a central role in the diagnostic assessment of a patient with a thyroid nodule. - Ablation of residual thyroid tissue with radioiodine (I-131) is recommended for all patients who have undergone total thyroidectomy. - Follow-up protocols distinguish between patients with a low risk of thyroid-carcinoma recurrence and those with a non-low risk of recurrence.
| Translated title of the contribution | Guideline 'Differentiated thyroid carcinoma', including diagnosis of thyroid nodules |
|---|---|
| Original language | Dutch |
| Pages (from-to) | 1777-1782 |
| Number of pages | 6 |
| Journal | Nederlands Tijdschrift voor Geneeskunde |
| Volume | 151 |
| Issue number | 32 |
| Publication status | Published - 11-Aug-2007 |
Keywords
- radioactive iodine
- thyrotropin
- fine needle aspiration biopsy
- follow up
- human
- human tissue
- Netherlands
- practice guideline
- review
- scoring system
- thyroid carcinoma
- thyroid nodule
- thyroidectomy